What Causes Pulmonary Hypertension In Newborns?

What Exactly Is Pulmonary Hypertension in Newborns?

Before birth, a baby’s lungs are filled with fluid and not yet used for breathing. Oxygen comes from the placenta through the umbilical cord. Because the lungs are not needed, the blood vessels in the lungs are naturally tight and narrow. Most of the blood bypasses the lungs through a special vessel called the ductus arteriosus.

At birth, everything should change. The first breaths inflate the lungs, fluid clears out, and oxygen enters. This signals the lung blood vessels to relax and open wide. Blood flow to the lungs increases dramatically. The ductus arteriosus closes. This is the normal transition.

In PPHN, that transition fails. The lung blood vessels stay tight. Blood cannot flow through the lungs easily. It gets shunted back through the ductus arteriosus or other openings, bypassing the lungs. The baby ends up with low oxygen in the blood, even if they are breathing hard. The CDC reports that PPHN affects about 2 in every 1,000 live births. It is a serious emergency in the neonatal intensive care unit (NICU).

What Causes Pulmonary Hypertension In Newborns?

The causes fall into three main categories: problems with lung development, problems during labor and delivery, and problems with the baby’s anatomy or other health conditions. Research published in the journal *Pediatrics* has helped clarify these categories.

The first category is underdeveloped lungs. Some babies are born with lungs that simply did not grow enough blood vessels. This is called pulmonary hypoplasia. It can happen when there is not enough amniotic fluid (oligohydramnios) or when the diaphragm did not form properly (congenital diaphragmatic hernia). With fewer blood vessels, the lungs cannot handle normal blood flow.

The second category is stress during delivery. When a baby is deprived of oxygen during labor or birth, it can trigger the blood vessels to clamp down. Meconium aspiration syndrome is a common example. The baby breathes in their first stool (meconium) mixed with amniotic fluid. This irritates the airways and causes the lung vessels to spasm. Other triggers include severe infection like sepsis or low blood sugar after birth.

The third category is structural problems with the heart or lungs. Some babies have congenital heart defects that force blood to bypass the lungs. Others have lung conditions like pneumonia or respiratory distress syndrome that make it hard for the lungs to expand properly. In some cases, no clear cause is ever found. This is called idiopathic PPHN.

How Is PPHN Different From Other Breathing Problems in Newborns?

Many newborns have trouble breathing in the first hours of life. But PPHN is different because the primary problem is the blood vessels, not the lung tissue itself. A baby with respiratory distress syndrome has stiff lungs that do not hold air well. A baby with PPHN has lungs that can hold air, but the blood cannot get through them.

This difference matters for treatment. With typical breathing problems, giving more oxygen and using a breathing machine often helps. With PPHN, the baby may need medications that specifically relax the blood vessels. These are called pulmonary vasodilators.

Doctors use an echocardiogram — an ultrasound of the heart — to confirm PPHN. This test shows the pressure in the lung arteries and whether blood is shunting away from the lungs. It is the only way to be sure. The American Academy of Pediatrics recommends an echocardiogram for any newborn with severe breathing trouble that does not improve with standard oxygen therapy.

What Are the Risk Factors for Developing PPHN?

Some babies are at higher risk than others. The strongest risk factors are related to the delivery and the baby’s condition at birth. Here is what the evidence shows:

• Meconium-stained amniotic fluid: This is the most common trigger. About 5% of all births have meconium in the fluid, and a small fraction of those babies develop PPHN.
• Cesarean delivery: Babies born by planned C-section before labor begins miss the hormonal surge that helps clear lung fluid and relax blood vessels. Studies suggest the risk of PPHN is about 5 times higher after elective C-section compared to vaginal delivery.
• Post-term birth: Babies born after 40 weeks have a higher chance of passing meconium and developing breathing problems.
• Maternal health conditions: Diabetes, high blood pressure, or obesity in the mother can affect the baby’s lung development and increase risk.
• Maternal use of certain medications: Some antidepressants, particularly SSRIs taken late in pregnancy, have been linked to a small increase in PPHN risk. The FDA has issued a warning about this, though the absolute risk remains low — about 3 to 10 cases per 1,000 births.

It is important to note that most babies with these risk factors do not develop PPHN. Risk factors just increase the odds. They do not guarantee the condition.

What Treatments Are Available and How Well Do They Work?

Treatment for PPHN has improved dramatically in the last 20 years. Before the 1990s, the death rate was very high. Now, with modern care, most babies survive.

The first step is always supportive care. The baby gets oxygen through a breathing tube or mask. A machine helps with breathing if needed. Blood pressure is supported with fluids or medications. The goal is to keep the baby stable while the lungs heal.

The specific treatment for PPHN is inhaled nitric oxide (iNO). This gas is delivered directly into the baby’s lungs through the breathing tube. It relaxes the blood vessels in the lungs without affecting the rest of the body. Research shows that iNO reduces the need for more invasive treatments like ECMO (a heart-lung bypass machine). About 70% of babies with PPHN respond to iNO.

For babies who do not respond to iNO, other options exist. Sildenafil, the same drug used for adult erectile dysfunction, can be given intravenously to help open lung blood vessels. Prostacyclin analogs like epoprostenol are also used. In the most severe cases, ECMO takes over the work of the heart and lungs, giving them time to heal. The Extracorporeal Life Support Organization reports that about 80% of newborns placed on ECMO for PPHN survive.

| Treatment | How It Works | Success Rate |
|———–|————–|————–|
| Inhaled nitric oxide (iNO) | Relaxes lung blood vessels directly | 70% respond |
| Intravenous sildenafil | Opens blood vessels throughout the body | Used when iNO fails |
| ECMO (heart-lung bypass) | Does the work of heart and lungs | 80% survival |
| Supportive care (oxygen, fluids) | Stabilizes the baby | Essential first step |

Can PPHN Be Prevented?

Not all cases can be prevented, but some steps reduce the risk. Avoiding elective C-sections before 39 weeks of pregnancy is one of the most effective. The American College of Obstetricians and Gynecologists recommends waiting until at least 39 weeks for scheduled C-sections unless there is a medical reason to deliver earlier.

Managing maternal health conditions like diabetes and high blood pressure during pregnancy also helps. Good prenatal care can reduce the chance of problems during labor that trigger PPHN.

For women taking SSRIs for depression, the decision is complex. Untreated depression during pregnancy carries its own risks for the baby. The small increase in PPHN risk must be weighed against the benefits of treating the mother’s mental health. This is a conversation to have with a doctor.

During labor, monitoring the baby’s heart rate can help detect signs of oxygen deprivation early. If problems arise, doctors can act quickly to deliver the baby or provide oxygen. But even with the best care, some cases of PPHN cannot be predicted or prevented.

What Is the Long-Term Outlook for Babies Who Survive PPHN?

Most babies who survive PPHN go on to live healthy lives. But some face long-term challenges. The severity of the condition and how quickly treatment started make a big difference.

Babies with mild to moderate PPHN who respond well to treatment typically have normal development. Studies show that by age 2, most of these children have no significant differences compared to their peers.

Babies with severe PPHN, especially those who needed ECMO, have a higher risk of problems. These can include hearing loss, speech delays, and learning difficulties. Research published in the *Journal of Pediatrics* found that about 15-20% of children who survived severe PPHN had some form of neurodevelopmental delay.

Regular follow-up is important. The American Academy of Pediatrics recommends hearing tests, vision checks, and developmental assessments for all children who had PPHN as newborns. Early intervention services can help if delays appear.